Legal Backgrounders

August 10, 2007

Legal Backgrounders

Recent Warning Letters For Ads Reflect FDA’s Fixation On “Substantial Evidence”

Download the PDF

By Arnold I. Friede, former Associate Chief Counsel in FDA’s Counsel’s Office.

Related Content

Working Papers

February 9, 2007

Pharmaceutical Advertising: “May You Live In Interesting Times”

By Arnold I. Friede,an attorney who previously served in the FDA's Chief Counsel's Office, and is currently Senior Corporate Counsel at Pfizer Inc.

Legal Opinion Letters

March 24, 2006

Advertising And Preemption Under FDA’s New Drug Labeling Rule

By Tish E. Pahl, a principal with Olsson, Frank and Weeda, P.C.

Legal Opinion Letters

February 20, 2004

FDA Guidance for “DTC” Ads Strives To Advance Consumer Understanding

By <a href="http://www.wrf.com/attorney/bio.asp?ID=H582744778" target="_blank" Rosemary C. Harold, a partner with the Washington, D.C. law firm Wiley Rein & Fielding LLP, and <a href="http://www.wrf.com/attorney/bio.asp?ID=K458416164" target="_blank"John F. Kamp, a counsel to the firm.